Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dth.13780 http://scihub22266oqcxt.onion/10.1111/dth.13780 32506775!7300491!32506775     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32506775&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32506775.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Dermatol+Ther 2020 ; 33 (4): e13780 Nephropedia Template TP {{tp|p=32506775|t=2020. Back to the basics: Propolis and COVID-19 |pdf=|usr=}}{{32506775}} gab.com Text Back to the basics: Propolis and COVID-19 JO: Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32506775 #FOAvip The epidemiological burden of COVID-19 is a healthcare challenge throughout the world, not only in terms of testing the limits of medical capacities, but also as an enigma considering preventive strategies and methods. The upper respiratory tract mucosa is the first line of defense, as a physical barrier, as well as through multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. Identifying methods able to reduce or prevent colonization, viral adhesion, and promote virus shedding on mucous membranes or have the ability to inactivate pathogens and thus reduce virus dose and/or increase immune response would be essential in the management of COVID-19 outbreak and help in flattening the curve. We review the effects of propolis, an old remedy with proven antiviral properties, as a possible low-cost inhibitor of SARS-CoV-2 in the oropharyngeal niche, prophylaxis, or adjuvant therapy. Twit Text FOAVip Back to the basics: Propolis and COVID-19 ????Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32506775 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32506775 #FOAvip English Wikipedia <ref>{{Cite pmid|32506775}}</ref> Back to the basics: Propolis and COVID-19 #MMPMID32506775 Bachevski D; Damevska K; Simeonovski V; Dimova M Dermatol Ther 2020[Jul]; 33 (4): e13780 PMID32506775show ga The epidemiological burden of COVID-19 is a healthcare challenge throughout the world, not only in terms of testing the limits of medical capacities, but also as an enigma considering preventive strategies and methods. The upper respiratory tract mucosa is the first line of defense, as a physical barrier, as well as through multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. Identifying methods able to reduce or prevent colonization, viral adhesion, and promote virus shedding on mucous membranes or have the ability to inactivate pathogens and thus reduce virus dose and/or increase immune response would be essential in the management of COVID-19 outbreak and help in flattening the curve. We review the effects of propolis, an old remedy with proven antiviral properties, as a possible low-cost inhibitor of SARS-CoV-2 in the oropharyngeal niche, prophylaxis, or adjuvant therapy. |*Betacoronavirus[MESH] |*Pandemics[MESH] |Anti-Infective Agents/therapeutic use[MESH] |COVID-19[MESH] |Coronavirus Infections/*drug therapy/epidemiology[MESH] |Humans[MESH] |Pneumonia, Viral/*drug therapy/epidemiology[MESH] |Propolis/*therapeutic use[MESH]Back to the basics: Propolis and COVID-19 (epmc).pdf DeepDyve Pubget Overpricing